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ABSTRACT 
Diacerein loaded microspheres were prepared by spray coating(wurster method) using hydroxyl propyl methyl cellulose (HPMC) and ethyl 
cellulose as release retarding polymer with a view to manufacture sustained release drug delivery. Drug content in the microspheres was 
determined by HPLC assay followed by drug entrapment efficiency.  Shape and Surface topography of Diacerein loaded microspheres was 
determined by scanning electron microscopy. Fourier transform infrared spectroscopy (.FT-IR), X-ray diffraction Spectroscopy (XRD), and 
Differential scanning calorimetry (DSC) studies were done to establish drug polymer and other excipients compatibility and stability. Sustained 
release action was established by In-vitro release study. The result shows that Diacerein loaded microsphere using hydroxyl propyl methyl 
cellulose and ethyl cellulose polymer can be a new addition in the field of pain management for the treatment of osteoarthritis.    
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INTRODUCTION 
Nowadays conventional dosage forms of drugs are rapidly 
being replaced by the new and novel drug delivery systems, 
among these sustained release or control release dosage 
forms are very popular in present day therapy.  Diacerein or 
Diacetylrhein comes under the class anthraquinone 
derivative. Chemically it is 9,10-dihydro-4,5-dihydroxy-9,10-
dioxo-2-anthranoic acid diacetate1. Diacerein is thought to 
act via inhibition of interleukin-1Beta, a protein involved  in 
the inflammation and destruction of cartilage that play a role 
in the development of symptoms of degenerative disease 
like osteoarthritis. Diacerein is a short acting drug, 
practically insoluble in water. Oral bioavailability of 
Diacerein is about 35to56%. Hence, the drug was selected 
for preparation of sustained release formulation. The study 
design was to prepare microsphere of Diacerein by spray 
coating with HPMC and ethyl cellulose as coating polymer 
which not only provides prolong therapeutic action but also 
reduce one of its major adverse side effect of Diacerein 
induced diarrhoea or soft stool and yellow color urine2-7. 
 
 
MATERIALS & METHODS  
For the present study Diacerein Mfgd by: M/s Elder 
Pharmaceuticals Ltd., A-36, MIDC, Industrial area, 
Patalganga, Mumbai was obtained as free gift. HPMC, Ethyl 
cellulose, MCC were from S. D. fine Chemicals Ltd. All other 
chemicals were of A. R. grade manufactured by Merk Ltd. 
and Sigma Aldrich.                                                                          
Instruments used:- 
* Mini Lab Coater, Manufacturer- Umnag Pharmatech Pvt. 
Ltd 
* HPLC – Perkin Elmer (Model Flexar) 
* Dissolution apparatus, Make Lab India, model DS 8000+ 
* IR – Shimadzu (Model Prestige 21) 
* Differential scanning Calorimetry (Model DSC 4000, 
software Pyris) 
Manufacturing process of Diacerein Microsphere:- 
1st Stage: Preparation of Drug pellet: 
Quantity of Dummy pallets taken for coating: - 300.0 gm.( 
size  #18-20) 
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Coating Solution formula: 
Sr. No. Ingredients Quantity (%) Quantity (g) 
1. Diacerein 5.34% 110.0g 
2. HPMC 6 cps 2.43% 50.0g 
3. Isopropyl alcohol (50%) 46.12% 950.0g 
4. Methylene Dichloride (50%) 46.12% 950.0g 
 Total: 100.00% 2060.0g 
Reconstitution: 7.77% w/w 
 
Procedure: 
 Weighed and mixed 110.0 g of Diacerein and 50.0 g of 
HPMC 6 cps and passed through # 40 mesh. 
 Added the above blend to Isopropyl Alcohol under 
stirring. Added weighed quantity of Methylene 
dichloride and continued stirring for 45 minutes. 
 Passed the above coating solution through #80 muslin 
cloth. 
 Stirring was continued during the entire coating process 
to avoid settling. 
Coating Parameters: 
Inlet temperature 40° C 
Product Temperature 31-34° C 
Exhaust Temperature 28-32°C 
Airflow (cfm) 6-8 
Drive (%) 45-60 
Atomization (bar) 1.5-1.7 
Spray pump (rpm) 1.0-4.0 
Process pump (rpm) 1.0-4.0 
Process time 6 hours 
Theoretical Weight gain: 36.67% 
Actual Weight gain: 35.00 % 
 
2nd Stage: Modified Release Coating: 
Quantity of Drug loaded pellets taken for coating: 405.0 g. 
Coating Solution formula: 
Sr. 
No. 
Ingredients Quantity (%) Quantity 
(g) 
1. Ethyl Cellulose 
N7 
4.95% 50.0g 
2. Dibutyl Phthalate 0.99% 10.0g 
3. IPA 47.03% 475.0g 
4. MDC 47.03% 475.0g 
 
Reconstitution: 5.94% w/w 
Procedure: 
 Weighed and mixed 50.0g of Ethyl Cellulose N7 and 
10.0g of Dibutyl Phthalate. 
 Added the above to Isopropyl alcohol under stirring. 
Added weighed quantity of Methylene Dichloride and 
continued stirring for 45 minutes. 
 Passed the above coating solution through # 80 mesh 
muslin cloth. 
Coating Parameters: 
Inlet temperature  40° C 
Product Temperature 31-35° C 
Exhaust Temperature 31-32° C 
Airflow (cfm) 7-8 
Drive (%) 55-65 
Atomization (bar) 1.0-1.9 
Spray pump (rpm) 1.0-5.0 
Process Time 4 hours 
Theoretical Weight gain: 14.81% 
Actual Weight gain: 13.58 % 
 
Evaluation of Diacerein microsphere 
Assay of Diacerein in microsphere by HPLC: The 
diacerein microsphere was assayed by HPLC following 
methods as described for assay of Diacerin capsules in IP 
2014 monograph. The assay was done on a C18 (15cm) 
column with Triethyl amine buffer (pH 3.0 with Phosphoric 
acid) and Acetonitrile in the ratio 75: 25 as mobile phase at a 
flow rate of 1.0 ml/min with 20 microlitre of load. The 
column was maintained at 40°C temperature and detection 
was carried out by UV visible detector at 254 nm. Perkin 
Elmer HPLC Model Flexar was used in the assay. The 
microsphere formulation was finely ground in morter pestle 
and accurately 0.035 g of pellet was taken in triplicate in 3 
separate 100 ml volumetric flasks and 70 ml diluents was 
added. Each solution was sonicated 15 min and volume was 
made up to the mark. Further 5 ml of each solution was 
diluted to 10 ml with diluents and these solutions were 
assayed against Diacerein standard solution of 0.05mg/ml. 
The average assay was calculated to be 146.17 mg/g of 
microsphere.  
Drug entrapment efficiency was calculated to be 61.08% 
In-vitro dissolution rate study of Diacerein microsphere: 
In vitro dissolution were performed for Diacerein 
microsphere using USP type II dissolution test apparatus 
(Paddle type) at 370C and 50rpm in Phosphate buffer PH 6.8 
and citrate buffer 6.0(500ml) dissolution medium.  An 
accurate amount of microsphere ( eqv. To 50mg Diacerein) 
was added to dissolution medium and at preset interval time 
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of 1,2,4,8,12,16,20,24hrs and 5ml aliquots were withdrawn 
and replaced by an equal volume of fresh dissolution 
medium. Aliquots following suitable dilution were analyzed 
by UV visible spectrophotometer at wavelength 254 nm for 
phosphate buffer and 340nm for citrate buffer.   
 
Table 1. Dissolution of Diacerein microsphere in Phosphate 
buffer pH 6.8 
Time (hr) Avg % of Drug Release  
    1 10.62 
    2 22.42 
    4 42.38 
    8 63.75 
   12 70.4 
   16 89.27 
   20 97.6 
   24 73.3 
 
 
Fig. 1 Dissolution of Diacerein microsphere in phosphate 
buffer pH 6.8 
 
Table. 2. Dissolution of Diacerein microsphere in Citrate 
buffer (Table -2) 
Time (hr) Avg % of Drug Release  
   1 8.28 
     2 20.01 
   4 31.89 
    8  38.58 
  12 48.09 
  16 50.12     
222    20 56.48 
  24 57.65 
 
 
Fig.2. Dissolution of Diacerein microsphere in citrate buffer 
 
 
Fig. 3.  Dissolution of Diacerein capsule (marketed 
preparation) in phosphate buffer pH 6.8 
 
Scanning Electron Microscope study of Diacerein loaded 
microsphere 
Scanning Electron Microscope (SEM) studies were carried 
out by using JEISS make (UK) model (JSM 6360). It was used 
to characterize the shape and surface topography of the 
microspheres. Microspheres were mounted on conducting 
stubs and vacuum coated with gold palladium film using a 
sputter coater (Edward S – 150, UK). Images were taken 
using 17kv electron beam intensity in a scanning electron 
microscope to examine the surface morphology of the 
microspheres.
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Fig. 4. SEM of Diacerein microsphere 
Fourier Transform Infrared Spectroscopy (FT-IR Study): 
Drug- polymer interactions were studied by FTIR 
spectroscopy in Shimadzu Japan (Model no. Prestige-21) 
Samples were prepared in Kbr dises (2mg sample in 200mg 
Kbr). FTIR study was performed on Diacerein, Microsphere 
and physical mixture. The scanning region was from 4000 to 
400cm-1. 
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Fig. 5. FTIR, of Diacerein API 
Mukhopadhyay et al                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(4):454-460 
  
ISSN: 2250-1177                                                                                  [458]                                                                                 CODEN (USA): JDDTAO 
5
3
1
.9
8
5
4
1
.8
1
5
5
1
.9
2
5
6
0
.3
0
5
6
6
.3
7
5
7
2
.6
6
5
7
9
.0
0
5
8
8
.0
9
5
9
5
.7
26
0
4
.6
4
6
1
1
.4
5
6
2
2
.0
3
6
2
7
.4
9
6
3
7
.1
6
6
4
8
.9
4
6
6
4
.1
2
6
7
2
.3
6
6
8
5
.5
9
7
0
7
.3
1
7
3
1
.4
0
7
4
5
.8
0
7
6
1
.0
7
7
6
9
.0
5
8
1
5
.6
6
8
3
8
.6
2
8
5
1
.7
5
8
6
3
.0
8
8
8
0
.8
6
8
9
9
.8
2
9
2
1
.3
4
1
0
2
6
.0
2
1
0
5
2
.4
3
1
0
9
9
.7
3
1
1
5
7
.5
6
1
2
0
5
.6
2
1
2
5
4
.3
3
1
2
9
0
.7
9
1
3
1
7
.8
6
1
3
6
8
.4
0
1
4
3
0
.1
0
1
4
4
8
.7
0
1
5
9
4
.0
3
1
6
7
8
.0
2
1
6
9
2
.9
1
1
7
6
8
.0
7
2
8
9
9
.1
9
3
3
2
9
.9
9
-20
 0
 20
 40
 60
 80
 100
 120
 140
 160
 180
%
T
ra
n
s
m
it
ta
n
c
e
 500    1000   1500   2000   2500   3000   3500   4000  
Wavenumbers (cm-1)  
Fig. 6. FTIR of Diacerein Microsphere 
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Fig. 7. FTIR of Diacerein with other ingredients physical mixture. 
 
X- Ray Diffraction Analysis: 
X-ray diffratometry of Diacerein, Diacerein loaded 
microsphere, and Physical mixture of Diacerein and other 
ingredients were done by using MODEL – ULTIMA-III, 
RIGAKU (MAKE JAPAN), Cu target slit 10mm. The samples 
were mounted on to the diffractometer and ciliated the X-
rays on to the powdered sample to get the diffraction peak of 
certain intensities and recorded scan speed and scan axis 
were 1.000deg/min and 20/0 respectively. 
 
 
 
Fig. 8. XRD of Diacerein API 
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Fig.9. XRD of Diacerein Microsphere 
 
Fig. 10. XRD of Physical Mixture of Diacerein and Ingredients 
Differential Scanning Calorimetry: 
DSC study of Diacerein API, microsphere and drug and 
ingredients physical mixture were studied in Perkin Elmer 
(model DSC 4000), software Pyris. DSC thermo grams were 
shown in fig 10, 11 &12) which shows drug stability and 
compatibility during the process. 
  
 
Fig. 10. DSC of Diacerein API 
 
Fig. 11.DSC of Diacerein Microsphere 
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Fig. 12. DSC of Physical Mixture of Diacerein and Ingredients 
 
RESULTS AND DISCUSSION 
Scanning Electron Microscope 
Scanning electron microscopy (SEM) of drug loaded 
microsphere of HPMC and ethyl cellulose reveals that the 
microspheres posses spherical, non-aggregated and porous 
surface (fig a, to, g) By SEM study it had been seen that the 
size of the optimized Diacerein loaded microsphere was 20 
µm to 100 µm. Magnification of 144, 261, 146 and 408 shows 
the spherical shape and partially porous nature of the 
microsphere. The formation of pore may cause solvent to 
penetrate resulting in the swelling of the internal matrix and 
release of the drug either burst release or through diffusion. 
Formation of pore means diffusion mechanism to be 
responsible for sustained release. 
FTIR Study 
The FTIR patterns of Diacerein(API), Diacerein microsphere 
and Diacerein and other ingredients physical mixture are 
shown in Fig S4B,S1B and S5B.The FT-IR spectra of pure 
Diacerein showed sharp peak at 1690 cm-1 ( which may be 
due to C=O stretching amide), 2937 cm-1( C-H stretching 
aliphatic) and 1766 cm-1( C=O Stretching ester). The 
identical peaks also present in Diacerein loaded microsphere 
and Physical mixture of Diacerein and other ingredients. The 
result shows drug stability during the process. 
X-RAY Diffraction Spectroscopy (XRD) 
X-ray diffraction Spectroscopy was done to establish the 
stability and compatibility of the Diacerein with other 
excipients when formulated into microsphere. The 
diffraction pattern of pure drug was compared with 
Diacerein microsphere and physical mixture of Diacerein 
with other ingredients used in formulating the microsphere. 
Since each diffraction pattern is characteristic to a specific 
crystalline lattice for a given compound, the purity and 
stability of the drug in the dosage form can be established 
through it. The X-ray diffraction pattern shows that there is 
little change in crystalline structure of Diacerein as pure 
drug, Diacerein microsphere and Physical mixture of 
Diacerein with other ingredients. Slight shift in Diacerein 
microsphere and Physical mixture of drug and other 
ingredients may take place due to reduction of purity of the 
drug during formulation of microsphere and physical 
mixture. 
Differential Scanning Calorimetry (DSC)   
The DSC analysis of Diacerein as pure drug, microsphere and 
Physical mixture of Diacerein and other ingredients elicited 
an endothermic peak very close to each other. Thus it was 
thought to indicate the absence of chemical interaction 
between the drug and polymer.    
In – vitro Drug Release Study 
The in-vitro release profile of Diacerein microsphere and 
Diacerein commercial capsule were compared. The drug 
release rates from the developed microspheres were 
significantly retarded when compared with commercially 
available capsule. Diacerein microspheres showed release 
retarding effect in both phosphate buffer at pH 6.8 and 
citrate buffer at pH 6.0.  
CONCLUSION 
The study confirms that Diacerein loaded microsphere can 
be prepared using HPMC and ethyl cellulose as release 
retarding polymers by spray coating method for sustained 
release drug delivery. Further study needs in vivo 
correlation.  
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